teal triangle graphic

Medical Education Grants

Medical Education Grants


Alkermes supports continuing medical education with grants for educational activities focused on pragmatic approaches to improving patient care and public health in the domains of schizophrenia, bipolar disorder, opioid use disorder and alcohol use disorder. We hope to contribute to an improved understanding of the underlying mechanisms of these diseases and their relevance to medications, as well as psychosocial interventions.

Grant funding may be available for activities, including live, print, enduring or web-based continuing medical education (CME) activities. Accredited CME activities are preferred.


Apply now

Who May Apply

Only organizations based in the U.S. may apply. Medical education grants may be awarded to (i) nonprofit organizations with tax exempt status under the U.S. Internal Revenue Code or (ii) for-profit organizations that are accredited continuing medical education providers.


How to Apply

Requests must be submitted online by the educational provider. Submissions are due at least 90 days in advance of the activity date. 



Application portal


Areas of Interest

Alkermes is currently accepting proposals that address the topic areas listed below. We are currently not awarding grants in the areas of Alcohol Use Disorder and Opioid Use Disorder. We will consider requests for addiction in Q4 2021.

Schizophrenia

  • Understanding and implementing pharmacologic approaches to address one or more of the following challenges in the treatment of schizophrenia:
    • Suboptimal therapeutic response
    • Gaps in medication adherence
    • Side effects associated with treatment
  • Emerging pharmacologic approaches and their mechanism of action for the treatment of schizophrenia
  • Using patient-centered approaches to optimize treatment of schizophrenia

Bipolar Disorder

  • Understanding and implementing pharmacologic approaches to address one or more of the following challenges in the treatment of bipolar disorder:
    • Suboptimal therapeutic response
    • Gaps in medication adherence
    • Side effects associated with treatment
  • Emerging pharmacologic approaches and their mechanisms of action for the treatment of bipolar disorder
  • Using patient-centered approaches to optimize treatment of bipolar disorder
teal triangle graphic

Additional Information

Alkermes is committed to complying with all applicable regulations and codes pertaining to education grants. Alkermes follows the requirements of the Compliance Program Guidance for Pharmaceutical Manufacturers issued by the Department of Health and Human Services Office of the Inspector General (“OIG Guidelines”), the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (“PhRMA Code”), the FDA Guidance to Industry Supported Scientific and Educational Activities and the Accreditation Council for Continuing Medical Education (“ACCME”) Standards for Commercial Support. Alkermes does not provide support for education programs that are intended to encourage, induce or influence any grant recipient to purchase, prescribe, refer, recommend, sell, administer or arrange for the purchase, sale or recommendation or formulary placement of any Alkermes product.
For more information, please contact: Med.Ed@alkermes.com.